PT  - JOURNAL ARTICLE
AU  - Okoroh, Ekwutosi M.
AU  - Kroelinger, Charlan D.
AU  - Sappenfield, Olivia R.
AU  - Howland, Julia F.
AU  - Romero, Lisa M.
AU  - Uesugi, Keriann
AU  - Cox, Shanna
TI  - Review of publicly available state reimbursement policies for removal and reinsertion of Long-Acting Reversible Contraception
AID  - 10.1101/2024.05.10.24307204
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.05.10.24307204
4099  - http://medrxiv.org/content/early/2024/05/12/2024.05.10.24307204.short
4100  - http://medrxiv.org/content/early/2024/05/12/2024.05.10.24307204.full
AB  - We examined reimbursement policies for the removal and reinsertion of long-acting reversible contraception (LARC). We conducted a standardized, web-based review of publicly available state policies for language on reimbursement of LARC removal and reinsertion. We also summarized policy language on barriers to reimbursement for LARC removal and reinsertion. Twenty-six (52%) of the 50 states had publicly available policies that addressed reimbursement for LARC removal. Of these, 14 (28%) included language on reimbursement for LARC reinsertion. Eleven states included language on barriers for reimbursement for removal and/or reinsertion: five state policies included language with other requirements for removal only, three policies included language with additional requirements for reinsertion only, and three included language with additional requirements for both. Three state policies specified no barriers be placed on reimbursement for removal and one specified no barriers be placed on reimbursement for reinsertion. Half of the states in the U.S. do not have publicly available policies on reimbursement for the removal and reinsertion of LARC devices. Inclusion of unrestricted access to these services is important for reproductive autonomy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was determined to be public health practice and, therefore, did not require Institutional Review Board approval at the Centers for Disease Control and Prevention or the University of Illinois at Chicago.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Not ApplicableData are all publicly available. Detailed search terms, data abstraction process, and methodology are described and referenced in the methodology section.